<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0004755'>Supraventricular tachycardia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e>) is a common tachyarrhythmia in the pediatric population that can necessitate immediate treatment </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="3" ids="16335">Adenosine</z:chebi> has been well studied as a mainstay treatment, but the methods of <z:chebi fb="3" ids="16335">adenosine</z:chebi> administration have not been very well delineated </plain></SENT>
<SENT sid="2" pm="."><plain>The intraosseous technique has presented itself as a possible method of administration </plain></SENT>
<SENT sid="3" pm="."><plain>We describe 2 cases in which <z:chebi fb="3" ids="16335">adenosine</z:chebi> was administered through bone marrow infusion to convert <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> without success </plain></SENT>
<SENT sid="4" pm="."><plain>The cases we describe show that intraosseous is not a reliable method of administering <z:chebi fb="3" ids="16335">adenosine</z:chebi> to stop <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Both patients presented with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SVT</z:e> refractory to vagal maneuvers and difficult intravenous placement </plain></SENT>
<SENT sid="6" pm="."><plain>Intraosseous access was achieved, but administration of <z:chebi fb="3" ids="16335">adenosine</z:chebi> at increasing doses was unable to successfully convert the <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> </plain></SENT>
</text></document>